Avidity Biosciences: Chardan Capital downgrades to Neutral from Buy, PT $72 from $75.

martes, 28 de octubre de 2025, 7:18 am ET1 min de lectura
RNA--

Avidity Biosciences: Chardan Capital downgrades to Neutral from Buy, PT $72 from $75.

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios